Sirnaomics Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Alan Patrick Lu
Chief executive officer
US$1.1m
Total compensation
CEO salary percentage | 47.4% |
CEO tenure | 3.8yrs |
CEO ownership | 10.7% |
Management average tenure | 1.5yrs |
Board average tenure | 3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | US$1m | US$515k | -US$79m |
Sep 30 2023 | n/a | n/a | -US$82m |
Jun 30 2023 | n/a | n/a | -US$84m |
Mar 31 2023 | n/a | n/a | -US$86m |
Dec 31 2022 | US$602k | US$520k | -US$88m |
Sep 30 2022 | n/a | n/a | -US$230m |
Jun 30 2022 | n/a | n/a | -US$223m |
Mar 31 2022 | n/a | n/a | -US$218m |
Dec 31 2021 | US$4m | US$379k | -US$213m |
Sep 30 2021 | n/a | n/a | -US$60m |
Dec 31 2020 | US$370k | US$276k | -US$44m |
Dec 31 2019 | US$379k | US$277k | -US$16m |
Compensation vs Market: Alan Patrick's total compensation ($USD1.09M) is above average for companies of similar size in the Hong Kong market ($USD233.84K).
Compensation vs Earnings: Alan Patrick's compensation has increased whilst the company is unprofitable.
CEO
Alan Patrick Lu (68 yo)
3.8yrs
Tenure
US$1,086,000
Compensation
Dr. Yang Lu, also known as Alan Patrick, PhD., is the founder, serves as Chairman of the Board, President & Chief Executive Officer at Sirnaomics Ltd. and has been its Director since October 15, 2020. He w...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, President & Chairman | no data | US$1.09m | 10.7% $ 39.8m | |
Head of Drug Discovery & Collaboration | less than a year | US$469.00k | 0.12% $ 463.4k | |
Senior Advisor - Drug Development & Commercialization and Executive Director | 2yrs | US$885.00k | 2.03% $ 7.5m | |
Vice President of Human Resources | 1.5yrs | no data | no data | |
Chief Production Officer | no data | no data | 0.0042% $ 15.4k | |
Company Secretary | no data | no data | no data |
1.5yrs
Average Tenure
61yo
Average Age
Experienced Management: 2257's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, President & Chairman | 3.8yrs | US$1.09m | 10.7% $ 39.8m | |
Senior Advisor - Drug Development & Commercialization and Executive Director | 3.5yrs | US$885.00k | 2.03% $ 7.5m | |
Independent Non Executive Director | 2.6yrs | US$69.00k | no data | |
Independent Non Executive Director | 2.6yrs | US$46.00k | no data | |
Independent Non-Executive Director | 2.6yrs | US$69.00k | no data | |
Non Executive Director | 3yrs | US$15.00k | no data | |
Non Executive Director | 3.5yrs | US$15.00k | 1.1% $ 4.1m |
3.0yrs
Average Tenure
67yo
Average Age
Experienced Board: 2257's board of directors are considered experienced (3 years average tenure).